Monte Rosa Therapeutics News

Monte Rosa Therapeutics | 8-K: Current report

May 3 04:09

Monte Rosa Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

May 2 04:30

Monte Rosa Therapeutics | DEFA14A: Others

Apr 27 04:44

Monte Rosa Therapeutics | ARS: Annual Report to Security Holders

Apr 27 04:34

Monte Rosa Therapeutics | DEF 14A: Definitive information statements

Apr 27 04:05

Monte Rosa Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 11 04:29

Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(10.2%)

Apr 11 01:02

Monte Rosa Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 15 04:11

Monte Rosa Therapeutics | 10-K: Annual report

Mar 14 19:48

Monte Rosa Therapeutics | 8-K: Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Mar 14 19:08

Monte Rosa Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Baker Bros. Advisors LP(9.8%),Baker Bros. Advisors (GP) LLC(9.8%), etc.

Feb 15 06:46

Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Global Healthcare Master Fund, LP(0.00%),Cormorant Global Healthcare GP, LLC(0.00%), etc.

Feb 15 04:09

Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.7%)

Feb 15 00:27

Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(9.9%)

Feb 14 23:20

Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(9.1%),Behzad Aghazadeh(9.1%)

Feb 14 22:17

Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(11.056%),Abigail P. Johnson(11.056%)

Feb 9 22:30

Monte Rosa Therapeutics | 8-K: Current report

Jan 8 13:00

Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dunn Edmund

Jan 4 13:00

Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wallace Owen B.

Jan 4 13:00

Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Warmuth Markus

Jan 4 13:00